Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. DEFA14A Proxy Proxy Materials
  4. DEF 14A Proxy Proxy Statement
  5. 4 Open-market sale Chief Operating Officer sold 831 shares at $13.17 ($10,944)
  6. 8-K Event Other events
  7. 8-K Event Executive or director change
  8. 4 Open-market sale SVP and General Counsel sold 2,387 shares at $11.44 ($27,307)
  9. 4 Open-market sale Chief Medical Officer sold 3,350 shares at $11.43 ($38,291)
  10. 4 Open-market sale Chief People Officer sold 3,582 shares at $11.44 ($40,978)
  11. 4 Open-market sale CEO and Chairman sold 44,445 shares at an average $11.80 ($524,352)
  12. 4 Grant or award Chief Commercial Officer acquired 65,898 shares (grant or award)
  13. 4 Open-market sale Chief Medical Officer sold 2,373 shares at $12.01 ($28,500)
  14. 4 Open-market sale President sold 4,613 shares at $12.01 ($55,402)
  15. 4 Open-market sale Chief Business Development Off sold 2,670 shares at $12.01 ($32,067)
  16. 4 Open-market sale SVP and General Counsel sold 1,569 shares at $12.01 ($18,844)
  17. 4 Open-market sale Principal Accounting Officer sold 220 shares at $12.01 ($2,642)
  18. 4 Open-market sale Chief People Officer sold 1,569 shares at $12.01 ($18,844)
  19. 4 Open-market sale Chief Scientific Officer sold 4,517 shares at $12.01 ($54,249)
  20. 4 Open-market sale CEO and Chairman sold 4,424 shares at $12.01 ($53,132)

Page 19 of 42 · 837 filings